The COVID-19 pandemic has had broad global ramifications and, while vaccine development is progressing, supplemental or alternative treatments for the virus are also crucial. PBG BioPharma has received Health Canada approved cannabis research license which allows us to research the potential therapeutical effects of Cannabis derived phytochemicals in the treatment or prevention of multi-viral infections, including SARS-Cov-2.
Read more here: https://pbgcannabis.com/products-and-services/laboratories/
